The power of negative thinking.
作者信息
Bloom B R
出版信息
J Clin Invest. 1993 Apr;91(4):1265-6. doi: 10.1172/JCI116322.
Abstract
摘要
相似文献
1
The power of negative thinking.
J Clin Invest. 1993 Apr;91(4):1265-6. doi: 10.1172/JCI116322.
2
Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment.
Ann N Y Acad Sci. 2007 Aug;1109:167-77. doi: 10.1196/annals.1398.020.
3
Tipping the balance towards tolerance: the basis for therapeutic immune modulation by gold?
Autoimmunity. 2005 Sep;38(6):393-7. doi: 10.1080/08916930500193531.
4
[Treatment of inflammation with anti-inflammatory cytokines: example in models of auto-immune diseases].
C R Seances Soc Biol Fil. 1995;189(4):579-90.
5
Cytokines and anti-cytokines as therapeutics--an update.
Eur J Pharmacol. 2008 Jan 28;579(1-3):1-12. doi: 10.1016/j.ejphar.2007.10.049. Epub 2007 Oct 25.
6
Altering immune tolerance therapeutically: the power of negative thinking.
J Leukoc Biol. 2004 Apr;75(4):586-99. doi: 10.1189/jlb.0803394. Epub 2003 Dec 4.
7
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
Nat Rev Immunol. 2007 Sep;7(9):665-77. doi: 10.1038/nri2153. Epub 2007 Aug 10.
8
[Cyclosporin A in inflammatory rheumatic diseases].
Internist (Berl). 1996 Jan;37(1):91-7.
9
Putting tolerance to the test.
Science. 2004 Jul 9;305(5681):194-6. doi: 10.1126/science.305.5681.194.
10
[Biological drugs in the treatment of immunoinflammatory diseases].
Ugeskr Laeger. 2008 Jun 9;170(24):2103.
引用本文的文献
1
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.
Clin Microbiol Rev. 1996 Oct;9(4):532-62. doi: 10.1128/CMR.9.4.532.
2
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
J Clin Invest. 1994 Feb;93(2):768-75. doi: 10.1172/JCI117031.
3
Cytokine therapeutics: lessons from interferon alpha.
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1198-205. doi: 10.1073/pnas.91.4.1198.
4
Divergent T-cell cytokine patterns in inflammatory arthritis.
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8562-6. doi: 10.1073/pnas.91.18.8562.
本文引用的文献
1
Cytokine patterns in the pathogenesis of human leishmaniasis.
J Clin Invest. 1993 Apr;91(4):1390-5. doi: 10.1172/JCI116341.
2
HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans.
Nature. 1987;327(6121):426-30. doi: 10.1038/327426a0.
3
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.
Lancet. 1987 Feb 21;1(8530):401-5. doi: 10.1016/s0140-6736(87)90116-4.
4
Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production.
Clin Immunol Immunopathol. 1990 Nov;57(2):242-9. doi: 10.1016/0090-1229(90)90038-r.
5
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
J Exp Med. 1990 Jan 1;171(1):115-27. doi: 10.1084/jem.171.1.115.
6
Functional subsets of allergen-reactive human CD4+ T cells.
Immunol Today. 1991 Nov;12(11):392-5. doi: 10.1016/0167-5699(91)90137-I.
7
Human TH1 and TH2 subsets: doubt no more.
Immunol Today. 1991 Aug;12(8):256-7. doi: 10.1016/0167-5699(91)90120-I.
8
Revisiting and revising suppressor T cells.
Immunol Today. 1992 Apr;13(4):131-6. doi: 10.1016/0167-5699(92)90110-S.
Zotero 插件